Page last updated: 2024-08-26

phorbolol myristate acetate and liraglutide

phorbolol myristate acetate has been researched along with liraglutide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Dai, Y; Mehta, JL	1

Other Studies

1 other study(ies) available for phorbolol myristate acetate and liraglutide

Article	Year
Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation. Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:5 Topics: Cells, Cultured; Endothelin-1; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Liraglutide; NF-kappa B; Nitric Oxide Synthase Type III; Receptors, Glucagon; Tetradecanoylphorbol Acetate	2013

Article

Year

Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation.

Cardiovascular drugs and therapy, 2013, Volume: 27, Issue:5

Topics: Cells, Cultured; Endothelin-1; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-6; Liraglutide; NF-kappa B; Nitric Oxide Synthase Type III; Receptors, Glucagon; Tetradecanoylphorbol Acetate

2013